Does OLANZAPINE Cause Hyperleukocytosis? 23 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Hyperleukocytosis have been filed in association with OLANZAPINE (Olanzapine). This represents 0.0% of all adverse event reports for OLANZAPINE.
23
Reports of Hyperleukocytosis with OLANZAPINE
0.0%
of all OLANZAPINE reports
10
Deaths
12
Hospitalizations
How Dangerous Is Hyperleukocytosis From OLANZAPINE?
Of the 23 reports, 10 (43.5%) resulted in death, 12 (52.2%) required hospitalization, and 1 (4.3%) were considered life-threatening.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does OLANZAPINE Cause?
Drug ineffective (5,139)
Weight increased (3,588)
Off label use (3,256)
Toxicity to various agents (3,175)
Somnolence (2,612)
Sedation (2,130)
Suicide attempt (2,116)
Confusional state (1,898)
Condition aggravated (1,810)
Overdose (1,765)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which OLANZAPINE Alternatives Have Lower Hyperleukocytosis Risk?
OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE
OLANZAPINE vs OLAPARIB
OLANZAPINE vs OLARATUMAB
OLANZAPINE vs OLECLUMAB
OLANZAPINE vs OLIVE OIL\SOYBEAN OIL